LABETALOL HYDROCHLORIDE INJECTION USP
Google image searchProduct monograph
Active ingredient
labetalol hydrochloride, 5 MG/ML
DIN: 02541505
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: MULTIDOSE VIAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 24-MAY-2024
ATC:
- C07 — BETA BLOCKING AGENTS (ATC, ATC/DDD, )
- C07A — BETA BLOCKING AGENTS (ATC, ATC/DDD)
- C07AG — Alpha and beta blocking agents (ATC, ATC/DDD)
- C07AG01 — LABETALOL (ATC/DDD)
Reference brand drug: Trandate
Pharmaceutical standard: USP
